NewslettersDermal Cell News eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma By Bob - May 30, 2022 0 Researchers revealed that eIF6 was highly over-expressed in melanomas compared to normal skin specimens, and thus the abnormally high level of eIF6 can be a diagnostic marker for melanoma. [Frontiers in Oncology] Full Article